Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
OCUP | Ocuphire Pharma | -1.15% | 73M |
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
There is no dividend information for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
OCUP | Ocuphire Pharma | -1.15% | 73M |
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
There is no dividend information for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
OCUP | Ocuphire Pharma | -1.15% | 73M |
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
There is no dividend information for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
OCUP | Ocuphire Pharma | -1.15% | 73M |
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
There is no dividend information for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
OCUP | Ocuphire Pharma | -1.15% | 73M |
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
There is no dividend information for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
OCUP | Ocuphire Pharma | -1.15% | 73M |
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
There is no dividend information for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
OCUP | Ocuphire Pharma | -1.15% | 73M |
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
There is no dividend information for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
OCUP | Ocuphire Pharma | -1.15% | 73M |
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
There is no dividend information for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Stock (NASDAQ: MIST) stock price, news, charts, stock research, profile.
Open3.080 | Close3.100 |
Vol / Avg.61.789K / 113.387K | Mkt Cap98.479M |
Day Range2.950 - 3.140 | 52 Wk Range2.680 - 9.700 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-14 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | 25.00 | 25.00 |
2023-06-20 | Jefferies | Chris Howerton | Downgrades | BuyHold | Lowers | 8.00 | 4.00 |
2023-05-23 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
2023-05-15 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | BuyBuy | Maintains | - | 25.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
MIST | Milestone Pharmaceuticals | -2.64% | 98.5M |
SCYX | SCYNEXIS | 2.17% | 87.4M |
OCUP | Ocuphire Pharma | -1.15% | 73M |
LBPH | Longboard Pharmaceuticals | 1.28% | 127.8M |
AQST | Aquestive Therapeutics | -0.67% | 99.4M |
You can purchase shares of Milestone Pharmaceuticals (NASDAQ: MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH), Aquestive Therapeutics (NASDAQ:AQST) and Esperion Therapeutics (NASDAQ:ESPR).
The latest price target for Milestone Pharmaceuticals (NASDAQ: MIST) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 25.00 expecting MIST to rise to within 12 months (a possible 747.46% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $2.95 last updated September 29, 2023 at 8:13 PM UTC.
There is no dividend information for Milestone Pharmaceuticals.
Milestone Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 9, 2023.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.